Spring Mountain Capital

Spring Mountain Capital is a growth equity investment firm established in 2001 and based in New York, New York. The firm specializes in providing expansion capital to companies that are leveraging breakthrough innovations and responding to significant market changes. It primarily invests in the U.S. lower middle market, focusing on sectors with high growth potential, including enterprise software, technology-enabled services, digital health, and healthcare services. Additionally, Spring Mountain Capital explores opportunities in life sciences, cybersecurity, e-commerce, impact investing, and virtual reality. As a Registered Investment Adviser, the firm aims to support companies that are positioned for substantial growth in a rapidly evolving economic landscape.

Wendy Furrer

Vice President

Jason L. Orchard

Managing Director and Head of Total Return

Kenneth Soll

Principal

William Xin

Executive Partner

Avi Faliks Ph.D

Managing Director

44 past transactions

Thentia Cloud

Series B in 2022
Thentia Corporation is an industry leader in using proprietary technology to help regulatory bodies efficiently fulfill their regulatory obligations. Thentia services a wide variety of clients throughout Canada and the United States using cutting-edge software and industry-leading expertise in regulatory standards.

Genomenon

Series B in 2022
Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and research. Founded in 2014, it provides a suite of diagnostic and discovery software that enables physicians, pharmaceutical companies, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. The flagship product, GENOMENON, automates the analysis of next-generation sequencing data, facilitating faster decision-making in cancer diagnosis and treatment, as well as in the study of inheritable diseases. By improving the efficiency of genomic interpretation, Genomenon aims to enhance patient outcomes and advance genetic research.

EverWash

Series B in 2022
EverWash operates a cloud-based subscription management platform designed specifically for the car wash industry. The company partners with local car washes to offer unlimited-use, monthly membership plans, allowing customers to wash their vehicles as frequently as desired. Its software as a service (SaaS) platform streamlines the membership sales and marketing processes, automating customer enrollment, billing, and revenue recognition. By optimizing these operations, EverWash helps its partners attract and retain more monthly members while enhancing revenue growth and reducing operational costs. This approach positions EverWash as a valuable resource for car wash businesses aiming to improve customer engagement and profitability.

Eyrus

Series A in 2022
Eyrus is a developer of a workforce management tool tailored for the commercial construction industry. The company focuses on collecting real-time labor data to generate actionable insights directly from the construction workforce. Its technology automatically gathers data and establishes baseline workforce requirements based on project schedules. Through advanced analytics, Eyrus enables clients to improve delivery, resource management, project safety, and overall efficiency, helping them meet deadlines and optimize project outcomes.

Koneksa

Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company based in New York, with an additional location in London. Founded in 2013, the company specializes in designing and developing software for pharmaceutical and biotech firms to facilitate decision-making and regulatory claims based on remotely generated patient data. Its flagship product, Koneksa Compare, provides a dashboard for capturing, monitoring, and analyzing patient-generated data and outcomes in clinical studies. The software supports the integration of emerging technologies, such as bio-sensors, activity trackers, and mobile-based questionnaires, allowing researchers to expand the range of analyzable data and reduce subjectivity in clinical endpoints. Koneksa Health aims to enhance the efficiency and accuracy of clinical research through its innovative solutions.

Ankyra

Series B in 2021
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.

Aware

Series C in 2021
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

RepairSmith

Series B in 2021
RepairSmith provides the world’s most convenient car repair and maintenance. For the first time, car owners can choose to get their repair delivered to their driveway or drop it off at our shop. We deliver an upfront price, online booking, after-hours support, and a full warranty.Their delivery mechanics are equipped with company vehicles and professional tools, trained and goaled on customer satisfaction.

Allyx Therapeutics

Venture Round in 2021
Allyx Therapeutics, founded in 2018 and located in Durham, Connecticut, is a clinical-stage biotechnology company focused on developing disease-modifying treatments for Alzheimer's Disease. The company specializes in a therapeutic drug that is an orally bioavailable small molecule, functioning as a silent allosteric modulator of mGluR5. This innovative approach aims to reverse neurodegeneration and preserve cognitive function in patients, offering a potential breakthrough in Alzheimer's treatment.

Thentia Cloud

Series B in 2021
Thentia Corporation is an industry leader in using proprietary technology to help regulatory bodies efficiently fulfill their regulatory obligations. Thentia services a wide variety of clients throughout Canada and the United States using cutting-edge software and industry-leading expertise in regulatory standards.

Aware

Series B in 2020
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. They have only built a fraction of what they imagined and now they are looking for incredibly talented people to help us achieve their aspirational vision.

Koneksa

Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company based in New York, with an additional location in London. Founded in 2013, the company specializes in designing and developing software for pharmaceutical and biotech firms to facilitate decision-making and regulatory claims based on remotely generated patient data. Its flagship product, Koneksa Compare, provides a dashboard for capturing, monitoring, and analyzing patient-generated data and outcomes in clinical studies. The software supports the integration of emerging technologies, such as bio-sensors, activity trackers, and mobile-based questionnaires, allowing researchers to expand the range of analyzable data and reduce subjectivity in clinical endpoints. Koneksa Health aims to enhance the efficiency and accuracy of clinical research through its innovative solutions.

Maven

Series C in 2020
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.

Maven

Series C in 2020
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.

IsoPlexis

Series C in 2020
IsoPlexis Corp is a life sciences company based in Branford, Connecticut, that specializes in developing a diagnostic platform designed to measure cellular immune responses in patients. Founded in 2013, the company's technology focuses on single-cell detection, allowing for the identification of diverse immune responses at the individual cell level. This platform plays a crucial role in assessing the safety and efficacy of therapeutics, as well as monitoring disease progression. By providing detailed insights into immune responses, IsoPlexis aims to enhance therapeutic development and inform clinical decision-making for healthcare professionals.

IsoPlexis

Series C in 2019
IsoPlexis Corp is a life sciences company based in Branford, Connecticut, that specializes in developing a diagnostic platform designed to measure cellular immune responses in patients. Founded in 2013, the company's technology focuses on single-cell detection, allowing for the identification of diverse immune responses at the individual cell level. This platform plays a crucial role in assessing the safety and efficacy of therapeutics, as well as monitoring disease progression. By providing detailed insights into immune responses, IsoPlexis aims to enhance therapeutic development and inform clinical decision-making for healthcare professionals.

Keen Decision Systems

Series A in 2019
Keen Decision Systems develops software-as-a-service designed to assist marketers in making informed, data-driven decisions. The company's technology provides a real-time resource that accurately calculates financial contributions across various marketing channels. This capability allows marketers to maximize profitability, increase revenue, and optimize their marketing investments while operating within a fixed budget. By leveraging Keen Decision Systems' tools, marketers can enhance their strategic decision-making processes and achieve better financial outcomes.

Maven

Series B in 2018
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.

RiskSense

Series B in 2018
RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform designed to assess and manage cybersecurity risks. The RiskSense Platform allows organizations to evaluate their cyber risk exposure, orchestrate remediation efforts, and monitor outcomes through a self-managed Software as a Service (SaaS) model. Key offerings include vulnerability assessments via RiskSense Vulnerability Discovery, which identifies misconfigurations and security weaknesses, and RiskSense Attack Surface Validation, which assesses vulnerabilities exploited by cyber adversaries. The platform employs risk-based scoring, analytics, and technology-accelerated penetration testing to provide actionable remediation plans and improve the efficiency of security and IT teams. Additionally, it delivers a comprehensive view of cybersecurity risk across organizational levels through the RiskSense Security Score (RS3), integrating internal and external vulnerability data, threat intelligence, and asset criticality to prioritize risk mitigation efforts. Founded in 2006 and headquartered in Sunnyvale, California, RiskSense also operates in Albuquerque, New Mexico, and India.

Vergent Bioscience

Series A in 2018
Vergent Bioscience, Inc. is a company that specializes in the development of molecularly-targeted imaging probes aimed at improving the surgical treatment of cancer. Founded in 2013 and based in Minneapolis, Minnesota, the company has created a fluorescent probe, VGT-309, which binds to enzymes overexpressed in tumor tissue. When administered before surgery, this probe activates a brightly fluorescing dye that highlights cancerous tissue, facilitating the identification and removal of tumors during surgical procedures. This innovative technology addresses the critical challenge surgeons face in distinguishing between cancerous and healthy tissues, which is essential for maximizing cure rates. Vergent's probes can identify multiple cancer types, including lung, breast, ovarian, colorectal, and brain cancers, and are designed to enhance visualization in various surgical approaches, including open, laparoscopic, and robotic surgeries.

ReNetX Bio

Series A in 2018
ReNetX Bio, Inc., a biotechnology company, develops and markets therapeutics to treat injury/damage to the central nervous system. It offers Nogo Trap, a decoy receptor that binds the growth inhibitors allowing the body to grow nerve fibers naturally and directly targeting restoration across all facets of growth, such as axonal regeneration, axonal sprouting, and synaptic plasticity. The company offers treatment for central nervous system for conditions, such as spinal cord injury, stroke, and glaucoma. ReNetX Bio, Inc. was formerly known as Axerion Therapeutics, Inc. and changed its name to ReNetX Bio, Inc. in July 2017. The company was incorporated in 2009 and is based in New Haven, Connecticut.

Home Captain

Series A in 2018
Home Captain Inc. is a real estate platform that offers agency services and connects home buyers and sellers with local realtors. Founded in 2013 and based in New York, the company has developed a network of real estate agents and utilizes a patent-pending system to match clients with pre-screened realtors in their area. Home Captain provides a range of services, including real estate agent screening and management, relocation program management, and property brokerage representation. Additionally, the platform assists mortgage lenders by ensuring that real estate agents remain under contract, facilitating a smoother buying and selling process for clients. Through its Real Estate Concierge, Home Captain aims to enhance the overall experience of navigating significant transactions in real estate.

180 Health Partners

Series B in 2018
180 Health Partners, Inc. specializes in addressing substance use and behavioral health challenges, particularly among expecting mothers. The company offers two main programs: The 180 Way, which combines personalized interdisciplinary treatment with a supportive ecosystem, and StrongWell, aimed at helping pregnant women overcome addiction to ensure the delivery of healthy babies. By facilitating multi-modal care coordination, 180 Health Partners connects opioid-addicted mothers with healthcare providers, allowing them to receive medical assistance in various settings, including their homes or preferred locations. Founded in 2016 and based in Franklin, Tennessee, the organization focuses on improving maternal health outcomes through accessible and comprehensive healthcare support.

IsoPlexis

Series B in 2017
IsoPlexis Corp is a life sciences company based in Branford, Connecticut, that specializes in developing a diagnostic platform designed to measure cellular immune responses in patients. Founded in 2013, the company's technology focuses on single-cell detection, allowing for the identification of diverse immune responses at the individual cell level. This platform plays a crucial role in assessing the safety and efficacy of therapeutics, as well as monitoring disease progression. By providing detailed insights into immune responses, IsoPlexis aims to enhance therapeutic development and inform clinical decision-making for healthcare professionals.

Maven

Series A in 2017
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.

SimpleReach

Series B in 2017
SimpleReach, Inc. offers a platform that tracks social interactions with published content, providing insights and metrics related to social behavior. By consolidating data from various channels and sites, it delivers a comprehensive overview of content performance. The company utilizes advanced machine learning and artificial intelligence techniques to generate actionable insights, enabling marketers to refine future campaigns and assisting publishers in creating dashboards for better reporting and improvement. Clients, including major brands like Intel and Chase, depend on SimpleReach to enhance their content marketing strategies and improve return on investment. Founded in 2010 and based in New York, SimpleReach operates as a subsidiary of Nativo, Inc.

Doctor.com

Series A in 2017
Doctor.com is the first marketing automation platform purpose-built for healthcare organizations. We've been first to market with leading reputation management and patient acquisition services including ProfileSync, ProfilePromote, and the Doctor.com ReviewHub, which was the subject of a case study on the Google Enterprise blog. All Doctor.com services connect to a proprietary network of leading consumer health and local business sites that collectively reach over 100M patients monthly, giving our clients an unrivaled advantage in their online marketing. As one of the fastest-growing SaaS companies in the healthcare vertical, they're fortunate to be backed by world-class investors and supported by a truly exceptional team.

Prevalent

Series B in 2016
Prevalent, Inc. specializes in third-party risk management software solutions and services, helping organizations assess and mitigate the risks associated with their vendors. The company's offerings include the Vendor Risk Manager, which aids security and compliance managers in evaluating vendor risks based on their significance, and the Vendor Threat Monitor, designed to track various risk areas such as data, operational, financial, and brand risks. Prevalent also provides a suite of compliance services tailored to meet global regulatory requirements, as well as professional services including vulnerability assessments and security incident management. Additional solutions include the Legal Vendor Network, which focuses on assessing third-party vendors for law firms, and the Healthcare Vendor Network, aimed at enhancing security and privacy measures in healthcare settings. Founded in 2004 and headquartered in Phoenix, Arizona, Prevalent operates multiple regional offices across the United States and has expanded its services to support clients in managing risk effectively while achieving compliance.

Oncoceutics

Series A in 2015
Oncoceutics, Inc. is a clinical-stage drug discovery and development company based in Philadelphia, Pennsylvania, founded in 2009. The company focuses on developing therapeutics that target critical signaling pathways in cancer. Its lead compound, ONC201, is an orally active DRD2 small molecule antagonist known for its significant anti-tumor activity across various cancer types through a unique mechanism of action. ONC201 has demonstrated compelling preclinical efficacy and a favorable safety profile, making it a promising candidate for clinical use. The company is actively conducting clinical trials for ONC201 at leading cancer centers globally, aiming to provide safe and effective treatment options for patients with advanced cancers. Additionally, Oncoceutics maintains strategic alliances with organizations such as the National Institutes of Health and Calvert Research, LLC, to enhance its research and development efforts.

Ziften

Series C in 2015
Ziften Technologies, Inc. is a cybersecurity company based in Austin, Texas, specializing in endpoint protection solutions. Founded in 2009, the company offers a cloud-delivered platform designed to safeguard enterprise endpoints, including laptops, desktops, servers, and cloud environments. Ziften's platform includes advanced antivirus, endpoint detection and response, and security posture analysis, enabling organizations to prevent cyber-attacks effectively. In addition to its protective measures, Ziften provides cyber risk assessments, managed detection and response services, and proactive threat hunting. Its clientele spans various sectors, including financial institutions, healthcare providers, energy companies, public sector institutions, and managed service providers, with operations extending to Europe, Australia and New Zealand, and the Middle East.

Activate Healthcare

Venture Round in 2015
Activate Healthcare, LLC operates healthcare clinics that focus on providing proactive and preventive primary care services. Founded in 2009 and headquartered in Indianapolis, Indiana, with an additional office in Chicago, the company delivers care for a variety of conditions, including respiratory infections, gastrointestinal disorders, and minor injuries. It also offers preventive services such as wellness exams, health screenings, and chronic condition management for issues like hypertension and diabetes. In addition, Activate Healthcare provides occupational health services addressing repetitive injuries and substance abuse testing. The company primarily serves government organizations, schools, and businesses in manufacturing and transportation sectors. By utilizing predictive modeling tools, Activate Healthcare aims to engage patients in managing their health proactively, thereby reducing health risks and improving overall wellness. As of January 2019, Activate Healthcare operates as a subsidiary of Paladina Health, LLC.

OpenSlate

Series A in 2015
OpenSlate is a leading provider of brand safety and contextual analytics for digital video content. Founded in 2012 by CEO Mike Henry and headquartered in New York, the company specializes in measuring the brand suitability of online content for advertisers. OpenSlate's platform offers advertisers targeted solutions that ensure alignment with appropriate content, rather than merely tracking exposure to potentially unsuitable material. Utilizing predictive data science, OpenSlate generates actionable metrics that assess the nature and quality of content across various platforms, particularly focused on YouTube but applicable to all digital video. The company serves every major advertising holding company and some of the largest global advertisers, helping them identify the most effective content for their advertising campaigns.

Oncoceutics

Venture Round in 2014
Oncoceutics, Inc. is a clinical-stage drug discovery and development company based in Philadelphia, Pennsylvania, founded in 2009. The company focuses on developing therapeutics that target critical signaling pathways in cancer. Its lead compound, ONC201, is an orally active DRD2 small molecule antagonist known for its significant anti-tumor activity across various cancer types through a unique mechanism of action. ONC201 has demonstrated compelling preclinical efficacy and a favorable safety profile, making it a promising candidate for clinical use. The company is actively conducting clinical trials for ONC201 at leading cancer centers globally, aiming to provide safe and effective treatment options for patients with advanced cancers. Additionally, Oncoceutics maintains strategic alliances with organizations such as the National Institutes of Health and Calvert Research, LLC, to enhance its research and development efforts.

Activate Healthcare

Private Equity Round in 2014
Activate Healthcare, LLC operates healthcare clinics that focus on providing proactive and preventive primary care services. Founded in 2009 and headquartered in Indianapolis, Indiana, with an additional office in Chicago, the company delivers care for a variety of conditions, including respiratory infections, gastrointestinal disorders, and minor injuries. It also offers preventive services such as wellness exams, health screenings, and chronic condition management for issues like hypertension and diabetes. In addition, Activate Healthcare provides occupational health services addressing repetitive injuries and substance abuse testing. The company primarily serves government organizations, schools, and businesses in manufacturing and transportation sectors. By utilizing predictive modeling tools, Activate Healthcare aims to engage patients in managing their health proactively, thereby reducing health risks and improving overall wellness. As of January 2019, Activate Healthcare operates as a subsidiary of Paladina Health, LLC.

IsoPlexis

Series A in 2014
IsoPlexis Corp is a life sciences company based in Branford, Connecticut, that specializes in developing a diagnostic platform designed to measure cellular immune responses in patients. Founded in 2013, the company's technology focuses on single-cell detection, allowing for the identification of diverse immune responses at the individual cell level. This platform plays a crucial role in assessing the safety and efficacy of therapeutics, as well as monitoring disease progression. By providing detailed insights into immune responses, IsoPlexis aims to enhance therapeutic development and inform clinical decision-making for healthcare professionals.

HμREL

Series A in 2013
HμREL® Corporation is an early-stage bioanalytic tools company with operations based in Kenilworth and New Brunswick, New Jersey, USA. Robert Freedman serves as Chief Executive Officer. Martin Yarmush is the Company’s Chief Scientific Adviser.

WhipTail

Series C in 2012
WhipTail Technologies specializes in the commercialization of all-flash enterprise storage arrays designed to resolve performance challenges in data centers. Since its inception in 2009, the company has provided solid-state storage solutions that significantly reduce delays associated with traditional hard disk drives, thereby enhancing data processing efficiency. WhipTail's flash-based arrays are installed globally across various mission-critical environments, including databases, virtualization, and online applications. By delivering exceptional input/output operations per second (IOPS), bandwidth, and reduced latency, WhipTail enables businesses to optimize their performance for demanding applications, transforming data processing times from months to days and hours to minutes.

OpenSlate

Series A in 2012
OpenSlate is a leading provider of brand safety and contextual analytics for digital video content. Founded in 2012 by CEO Mike Henry and headquartered in New York, the company specializes in measuring the brand suitability of online content for advertisers. OpenSlate's platform offers advertisers targeted solutions that ensure alignment with appropriate content, rather than merely tracking exposure to potentially unsuitable material. Utilizing predictive data science, OpenSlate generates actionable metrics that assess the nature and quality of content across various platforms, particularly focused on YouTube but applicable to all digital video. The company serves every major advertising holding company and some of the largest global advertisers, helping them identify the most effective content for their advertising campaigns.

WhipTail

Series B in 2012
WhipTail Technologies specializes in the commercialization of all-flash enterprise storage arrays designed to resolve performance challenges in data centers. Since its inception in 2009, the company has provided solid-state storage solutions that significantly reduce delays associated with traditional hard disk drives, thereby enhancing data processing efficiency. WhipTail's flash-based arrays are installed globally across various mission-critical environments, including databases, virtualization, and online applications. By delivering exceptional input/output operations per second (IOPS), bandwidth, and reduced latency, WhipTail enables businesses to optimize their performance for demanding applications, transforming data processing times from months to days and hours to minutes.

Cleaire

Venture Round in 2011
Cleaire Advanced Emission Controls, LLC specializes in designing, developing, and manufacturing retrofit emission control systems for diesel engines. The company provides a comprehensive range of products, including diesel particulate filters and specialized systems for both on-road and off-road vehicles. Its offerings are notable for their compliance with environmental standards, as all products are Level 3 verified by the California Air Resources Board. Cleaire's latest innovation, the LongMile®, represents a significant enhancement over existing market options. The company distributes its products through a network of dealers across North America and is headquartered in San Leandro, California. Founded in 2001, Cleaire continues to focus on improving air quality through its advanced emission control technologies.

WhipTail

Series A in 2011
WhipTail Technologies specializes in the commercialization of all-flash enterprise storage arrays designed to resolve performance challenges in data centers. Since its inception in 2009, the company has provided solid-state storage solutions that significantly reduce delays associated with traditional hard disk drives, thereby enhancing data processing efficiency. WhipTail's flash-based arrays are installed globally across various mission-critical environments, including databases, virtualization, and online applications. By delivering exceptional input/output operations per second (IOPS), bandwidth, and reduced latency, WhipTail enables businesses to optimize their performance for demanding applications, transforming data processing times from months to days and hours to minutes.

NXTM

Private Equity Round in 2011
Led by a former senior MTV executive, NXTM powers the digital presence for superstars Taylor Swift, Justin Timberlake, and Lenny Kravitz. Via its platform WHOOZNXT, NXTM equips emerging artists with these same tools and top-tier exposure opportunities. With major media partnerships in television, radio, live venues, digital platforms, and more - WHOOZNXT is the only platform that rewards the online activity of artists with real-world exposure.

Coolerado

Series B in 2010
Coolerado Corporation specializes in the design, manufacture, and marketing of energy-efficient air conditioning systems for light commercial and residential applications. Founded in 2004 and headquartered in Denver, Colorado, the company utilizes proprietary and patented technology to create air conditioning solutions that significantly reduce energy consumption. Coolerado's product line includes heat and mass exchangers, compact modular air conditioners, and energy recovery ventilators, which serve a diverse range of sectors such as data centers, schools, healthcare, retail, and government. With a focus on improving indoor air quality while minimizing carbon emissions, Coolerado caters to customers through a network of dealers worldwide. As of June 2015, Coolerado operates as a subsidiary of Seeley International Pty Ltd.

Perquest

Series B in 2007
Perquest is redefining workforce solutions through technology, service and process innovations. They are serious about service: Perquest is dedicated to making service their competitive advantage. They are committed to service at the highest levels of our organization, and have established a service culture, and tools, that allow us to live and breathe "service" every day. Specifically, they are integrated advanced customer relationship (CRM) technology into offering and made it accessible to everyone: employees, customers and partners. This enables maximum transparency between your organization and theirs; through highly secure Client Portal, you can contact Perquest and get a response within minutes. Perquest makes it easy: The company philosophy is exactly that: "Make it easy." That's why they deliver a mix of high-touch, full-service managed payroll and SaaS-based premier HR applications that are extremely easy to use — by anyone. The solutions are rock-solid: Reliability is the hallmark of Perquest workforce solutions. Market-proven to meet the demands of mid-size companies like yours, they deliver a single platform that integrates the workforce solutions you need with the CRM capabilities Perquest leverages to provide the utmost in service.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.